Table 1.
Distribution of age, gender, clinical and pathological diagnoses.
| Data available in n cases | ||
|---|---|---|
| Age in years (mean/range) | 57,5/0–85 | 62 |
| Gender (M/F) | 45/17 | 62 |
| Atrial fibrillation (y/n) | 9/42 | 51 |
| Arterial hypertension (y/n) | 26/36 | 62 |
| Myocardial infarction (y/n) | 9/53 | 62 |
| Heart weight/g (mean/range) | 410/8–850 | 62 |
| Degree of cardiac fibrosis (mean/range) | 1.56/0–3 | 62 |
| Degree of hypertension-related cardiac fibrosis (mean/range) | 0,694/0–3 | 62 |
| p62-positive BD inclusions/mm² (left ventricle) (mean/range) | 0.084/0–0.804 | 62 |
| Diabetes mellitus (y/n) | 9/53 | 62 |
| Hyperlipoproteinemia (y/n) | 10/28 | 38 |
| Obesity (y/n) | 15/23 | 38 |
| Intracerebral hemorrhage (y/n) | 8/54 | 62 |
| Cerebral infarction (y/n) | 16/46 | 62 |
| Athersclerosis (mean/range) | 31,25%/0–100% | 59 |
| Stage of SVD (mean/range) | 1.6/0–3 | 62 |
| Severity grade of CAA (mean/range) | 0,23/0–2 | 62 |
| Aβ-phase (MTL) (mean/range) | 0.65/0–4 | 62 |
| Braak NFT-stage (mean/range) | 1.18/0-4 | 62 |
| CERAD-score (mean/range) | 0.13/0–2 | 62 |
| NIA-AA degree of AD (mean/range) | 0.39/0–2 | 62 |
Numbers of cases, age-spectrum, cardiac and AD-related pathologies and parameters, arterial hypertension, diabetes mellitus, atherosclerosis, cerebral small vessels disease (SVD), CAA, and heart weights: Mean values and ranges. The list of the individual cases is provided in Supplementary Table 1.